«Sulfasalazine (SSZ), sold under the trade nameAzulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first line treatment in rheumatoid arthritis. It is taken by mouth.
Significant side effects occur in about 25% of people. Commonly these include loss of appetite, nausea, headache, and rash. Severe side effects include bone marrow suppression, liverproblems, and kidneyproblems. It should not be used in people allergic to aspirin or sulfonamide. Use during pregnancy appears to be safe for the baby.Sulfasalazine is in the disease-modifying antirheumatic drugs (DMARDs) family of medications. It is unclear exactly how it works but is broken down into sulfapyridine and 5-aminosalicylic acid.
Sulfasalazine was approved for medical use in the United States in 1950. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.Sulfasalazine is available as a generic medication. The wholesale cost in the developing world is about US$9–33 a month. In the United States it costs $25–50 per month.» (wikipedia)
Summary on Sulfasalazine
Our overview of this drug is quite short so far, as we are still gathering information.
Biolinks for Sulfasalazine are extracted by users from 1 related publications.
Users read a research at the PubMed. They understand a relation between two objects.
To organise this new finding, they add it as a new piece of information — a Biolink — a proven logical relation between objects, drugs or symptoms etc.
Any user can propose new knowledge which will be reviewed.
Proofs for biolinks of current node (Sulfasalazine) are listed here. Abstracts are hidden.